Promising activity of gemcitabine in refractory high-grade non-Hodgkin's lymphoma

British Journal of Haematology

Volumn 101, Issue 1, 1998, Pages 203-204

  Bernell, Per ^a   Ohm, Lotta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Gemcitabine; Non Hodgkin's lymphoma; Refractory

Indexed keywords

GEMCITABINE; LACTATE DEHYDROGENASE;

AGED; ARTICLE; B CELL LYMPHOMA; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; NONHODGKIN LYMPHOMA; PILOT STUDY; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; TREATMENT OUTCOME;

EID: 0031959221     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00667.x     Document Type: Article

References (6)

1. Cabanillas, F., Hagemeister, F.B., McLaughlin, P., Valasquez, W.S., Riggs, S., Fuller, L. & Smith, T. (1987) Results of MIME salvage regimen for recurrent or refractory lymphoma. Journal of Clinical Oncology, 5, 407-412.
2. Csoka, K., Liliemark, J., Larsson, R. & Nygren, P. (1995) Evaluation of the cytotoxic activity of tumor cells from patients with hematologic or solid tumors. Seminars in Oncology 22, 47-53.
3. Heinemann, V., Hertel, L.W., Grindey, G.B. & Plunkett, W. (1988) Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-beta-darabinofuranosylcytosine. Cancer Research, 48, 4024-4031.
4. Huang, P. & Plunkett, W. (1995) Induction of apoptosis by gemcitabine. Seminars in Oncology, 22, 19-25.
5. Pollera, C.F. (1997) More is better but⋯ How is best: Are milligrams over hour better than grams over minutes? The case of gemcitabine. Journal of Clinical Oncology, 15, 2172-2176.
6. Veerman, G., Ruiz van Haperen, V.W.T., Vermorken, J.B., Noordhuis, R. Braakhuis, B.J., Pindo, M.M. & Peters, G.J. (1996) Antitumor activity of prolonged as compared with bolus administration of 2′,2′-difluorodeoxycytidine in vivo against murine colon tumors. Cancer Chemotherapy and Pharmacology, 38, 335-342.